Cameron Durrant - Jan 12, 2022 Form 4 Insider Report for HUMANIGEN, INC (HGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Cameron Durrant
Stock symbol
HGEN
Transactions as of
Jan 12, 2022
Transactions value $
$0
Form type
4
Date filed
1/14/2022, 04:06 PM
Previous filing
Jan 4, 2022
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +84.4K $0.00 84.4K Jan 12, 2022 Common Stock 84.4K $2.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted to the Reporting Person at the direction of the Company in satisfaction of amounts earned under the Company's 2021 annual incentive plan.